Elisabeth Pauline Pickett (1918-): Opening the Door for Women in Urological Oncology

Jennifer H Yang, S. Machele Donat

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Purpose: We outline the career of Elisabeth Pauline Pickett (1918-), the first board certified female urologist. Materials and Methods: The historical literature including personal writings of Pickett and her mentors were reviewed. The factors which determine female medical student career choice as well as a summary of the current status of women in urology were also examined. Results: The groundwork for women in the modern era of urology was forged by Mary E. Childs MacGregor, who also supported and encouraged fellowship training. Inspired by Doctor MacGregor's example, Elisabeth Pickett became the first female general surgeon to complete a fellowship in urological oncology in 1955 under Dr. Willet Whitmore at Memorial Sloan-Kettering, and to be board certified in urology in 1962. Despite the benchmark set by these early pioneers the American Board of Urology currently lists only 324 female board certified urologists, 86 female candidates and 20 board eligible individuals as of the year 2006. Conclusions: Although the number of female graduating medical students in modern times is equivalent to males, there still exists a large discrepancy in the number of women choosing urology and other surgical subspecialties as a career. Elisabeth Pickett demonstrated that it could be done at a time when few thought it possible. However, only a minority of women today continue to pursue fellowship training.

Original languageEnglish (US)
Pages (from-to)1875-1877
Number of pages3
JournalJournal of Urology
Volume178
Issue number5
DOIs
StatePublished - Nov 2007
Externally publishedYes

Keywords

  • 20th century
  • history
  • medical oncology
  • urology
  • women

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Elisabeth Pauline Pickett (1918-): Opening the Door for Women in Urological Oncology'. Together they form a unique fingerprint.

Cite this